Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer-Reference-Cited by-同舟云学术

Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer

Published:2014-05-23 Issue:12 Volume:135 Page:2857-2867
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gauttier Vanessa¹,Judor Jean-Paul¹,Le Guen Valentin¹,Cany Jeannette²,Ferry Nicolas²,Conchon Sophie¹

Affiliation:

1. INSERM UMR1064, Centre for Research in Transplantation and Immunology-ITUN; Université de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu; Nantes France

2. INSERM UMR948, Hepatic Biotherapies; Université de Nantes, Centre Hospitalier Universitaire Hôtel Dieu; Nantes France

Funder

Fonds Unique Interministériel

ligue contre le cancer grand ouest

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Hepatocellular carcinoma-epidemiological trends and risk factors;Schutte;Dig Dis,2009

2. Novel advancements in the management of hepatocellular carcinoma in 2008;Llovet;J Hepatol,2008

3. Chronic inflammation, #immune |escape, and oncogenesis in the liver: a unique neighborhood for novel intersections;Stauffer;Hepatology,2012

4. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection;Gao;J Clin Oncol,2007

5. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma;Mizukoshi;Hepatology,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 ⁺ T cells in cis and in trans;Science Advances;2024-08-23

2. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

3. Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-11

4. Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma;American Journal of Clinical Dermatology;2024-02-08

5. The Roles of Myeloid-Derived Suppressor Cells in Liver Disease;Biomedicines;2024-01-27